Investment Research report

AMETEK, Inc.

NYSE:
ame
Previous Item
All Reports
AMETEK, Inc.
Testing & Measuring True Earnings
Download Report
AMETEK, Inc.
Download Report 2
AMETEK, Inc.
Download Report 3
AMETEK, Inc.
Download Report 4
AMETEK, Inc.
Download Report 5
AMETEK, Inc.
Download Report 6
AMETEK, Inc.
Download Report 7

Research Overview

INDEX:
S&P 500
Sector:
Industrials
Position:
Short
Date:
Nov 13, 2014

After conducting a forensic financial and accounting review, Spruce Point believes AMETEK Inc (NYSE: AME), a multinational conglomerate company, is under pressure as its strategy appears to be hitting a brick wall, continues to underinvest in R&D, and has a history of buying what it cannot develop. Based on our latest investigation, we estimate a 30% to 50% downside risk, or $27.00 - $36.00 per share.

Downloads & More

Research Assets & Releases

Press Releases

Nothing posted currently

Broadcast Coverage

Nothing posted currently

Join The Mailing List

Spruce Point Alerts & Updates

See the other side of the Wall Street hype machine.